Abbonarsi

Development and validation of artificial neural networks model for detection of Barrett’s neoplasia: a multicenter pragmatic nonrandomized trial (with video) - 18/02/23

Doi : 10.1016/j.gie.2022.10.031 
Mohamed Abdelrahim, MRCP 1, Masahiro Saiko, MSc 2, Naoto Maeda, MSc 3, Ejaz Hossain, MRCP 1, Asma Alkandari, MD 4, Sharmila Subramaniam, PhD 1, Adolfo Parra-Blanco, PhD 5, Andres Sanchez-Yague, PhD 6, Emmanuel Coron, PhD 7, Alessandro Repici, PhD 8, Pradeep Bhandari, MD 1, ⁎
1 Portsmouth Hospitals University NHS Trust, Portsmouth, UK 
2 Biometrics Research Laboratories, NEC Corporation, Kawasaki, Japan 
3 Medical AI Research Department, NEC Corporation, Tokyo, Japan 
4 Al Jahra Hospital, Kuwait, Kuwait 
5 Nottingham Digestive Diseases Biomedical Research Centre, and Nottingham University Hospitals NHS Trust, Nottingham, UK 
6 Hospital Costa del Sol, Marbella, Spain 
7 Centre Hospitalier Universitaire and Faculté de Médecine de Nantes, Nantes, France 
8 Humanitas Clinical and Research Center, Milan, Italy 

∗Reprint requests: Pradeep Bhandari, MD, Queen Alexandra Hospital, Southwick Hill Road, Cosham, Portsmouth PO6 3LY, UK.Queen Alexandra HospitalSouthwick Hill RoadCoshamPortsmouthPO6 3LYUK

Abstract

Background and aims

The aim of this study was to develop and externally validate a computer-aided detection (CAD) system for the detection and localization of Barrett’s neoplasia and assess its performance compared with that of general endoscopists in a statistically powered multicenter study by using real-time video sequences.

Methods

In phase 1, the hybrid visual geometry group 16-SegNet model was trained by the use of 75,198 images and videos (96 patients) of neoplastic and 1,014,973 images and videos (65 patients) of nonneoplastic Barrett’s esophagus. In phase 2, image-based validation was performed on a separate dataset of 107 images (20 patients) of neoplastic and 364 images (14 patients) of nonneoplastic Barrett’s esophagus. In phase 3 (video-based external validation) we designed a real-time video-based study with 32 videos (32 patients) of neoplastic and 43 videos (43 patients) of nonneoplastic Barrett’s esophagus from 4 European centers to compare the performance of the CAD model with that of 6 nonexpert endoscopists. The primary endpoint was the sensitivity of CAD diagnosis of Barrett’s neoplasia.

Results

In phase 2, CAD detected Barrett’s neoplasia with sensitivity, specificity, and accuracy of 95.3%, 94.5%, and 94.7%, respectively. In phase 3, the CAD system detected Barrett’s neoplasia with sensitivity, specificity, negative predictive value, and accuracy of 93.8%, 90.7%, 95.1%, and 92.0%, respectively, compared with the endoscopists’ performance of 63.5%, 77.9%, 74.2%, and 71.8%, respectively (P < .05 in all parameters). The CAD system localized neoplastic lesions with accuracy, mean precision, and mean intersection over union of 100%, 0.62, and 0.54, respectively, when compared with at least 1 of the expert markings. The processing speed of the CAD detection and localization were 5 ms/image and 33 ms/image, respectively.

Conclusion

To our knowledge, this is the first study describing external (multicenter) validation of AI algorithms for the detection of Barrett’s neoplasia on real-time endoscopic videos. The CAD system in this study significantly outperformed nonexpert endoscopists on real-time video-based assessment, achieving >90% sensitivity for neoplasia detection. This result needs to be validated during real-time endoscopic assessment.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : AI, ASGE, CADe, CNN, HGD, IoU, LGD, NPV, WLI


Mappa


 DISCLOSURE: This investigator-initiated study was funded by NEC Japan. M. Saiko is an AI researcher employed by NEC Japan. N. Maeda is an AI scientist employed by NEC Japan. The remaining authors disclosed no financial relationships.


© 2023  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 97 - N° 3

P. 422-434 - marzo 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Early (<4 weeks) versus standard (≥4 weeks) endoscopic drainage of pancreatic walled-off fluid collections: a systematic review and meta-analysis
  • Daryl Ramai, Ikponmwosa Enofe, Smit S. Deliwala, Daniel Mozell, Antonio Facciorusso, Paraskevas Gkolfakis, Babu P. Mohan, Saurabh Chandan, Melissa Previtera, Marcello Maida, Andrea Anderloni, Douglas G. Adler, Andrew Ofosu
| Articolo seguente Articolo seguente
  • Development and validation of a machine learning–based model for varices screening in compensated cirrhosis (CHESS2001): an international multicenter study
  • Yifei Huang, Jia Li, Tianlei Zheng, Dong Ji, Yu Jun Wong, Hong You, Ye Gu, Musong Li, Lili Zhao, Shuang Li, Shi Geng, Na Yang, Guofeng Chen, Yan Wang, Manoj Kumar, Ankur Jindal, Wei Qin, Zhenhuai Chen, Yongning Xin, Zicheng Jiang, Xiaoling Chi, Jilin Cheng, Mingxin Zhang, Huan Liu, Ming Lu, Li Li, Yong Zhang, Chunwen Pu, Deqiang Ma, Qibin He, Shanhong Tang, Chunyan Wang, Shanghao Liu, Jitao Wang, Yanna Liu, Chuan Liu, Hao Liu, Shiv Kumar Sarin

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.